- Training
- September 2026
- 2 Days
Global
€1547EUR$1,775USD£1,299GBP
€1786EUR$2,048USD£1,499GBP
- Report
- March 2026
- 281 Pages
Global
From €6313EUR$6,995USD£5,484GBP
- Report
- April 2025
- 285 Pages
Global
From €5182EUR$5,943USD£4,350GBP
- Report
- August 2025
- 114 Pages
Global
From €2391EUR$2,650USD£2,078GBP
- Report
- September 2025
- 634 Pages
Global
From €6453EUR$7,150USD£5,606GBP
- Report
- April 2025
- 75 Pages
Global
From €2166EUR$2,400USD£1,882GBP
- Report
- May 2025
- 150 Pages
Global
From €5370EUR$5,950USD£4,665GBP
- Report
- March 2026
- 481 Pages
Global
From €5279EUR$5,850USD£4,587GBP
- Report
- March 2026
- 478 Pages
Global
From €5279EUR$5,850USD£4,587GBP
- Report
- March 2026
- 177 Pages
Global
From €5279EUR$5,850USD£4,587GBP
- Report
- March 2026
- 473 Pages
Global
From €5279EUR$5,850USD£4,587GBP
- Report
- March 2026
- 118 Pages
Global
From €5279EUR$5,850USD£4,587GBP
- Report
- March 2026
- 135 Pages
Global
From €5279EUR$5,850USD£4,587GBP
- Report
- March 2026
- 408 Pages
Global
From €5279EUR$5,850USD£4,587GBP
- Report
- March 2026
- 214 Pages
Global
From €5279EUR$5,850USD£4,587GBP
- Report
- February 2026
- 250 Pages
Global
From €4052EUR$4,490USD£3,520GBP
- Report
- February 2026
- 250 Pages
Global
From €4052EUR$4,490USD£3,520GBP
- Report
- February 2026
- 250 Pages
Global
From €4052EUR$4,490USD£3,520GBP
- Report
- February 2026
- 250 Pages
Global
From €4052EUR$4,490USD£3,520GBP
- Report
- February 2026
- 250 Pages
Global
From €4052EUR$4,490USD£3,520GBP

The Drug Approval market is a key component of the Drug Discovery process. It involves the evaluation of a drug's safety and efficacy by regulatory authorities, such as the US Food and Drug Administration (FDA). This process is essential for the approval of a drug for commercial use. It involves the submission of a New Drug Application (NDA) to the FDA, which includes data from pre-clinical and clinical trials. The FDA then reviews the data and makes a decision on whether to approve the drug. The Drug Approval market is highly competitive, with many companies vying for approval of their drugs.
Companies in the Drug Approval market include pharmaceutical companies such as Pfizer, Merck, and GlaxoSmithKline, as well as biotechnology companies such as Amgen and Genentech. Other companies involved in the market include contract research organizations (CROs) and clinical research organizations (CROs). Show Less Read more